Skip to main content
. 2015 Mar 9;158(2):115–125. doi: 10.1093/jb/mvv028

Fig. 3.

Fig. 3

Mutant RPE65s formed high molecular weight complexes (HMC) via disulfide bonds. ARPE-19 cells expressing WT or the indicated mutant RPE65 were treated with inhibitor of ubiquitin-activating enzyme (UBEI-41) and subjected to immunoblot analysis in the presence or absence of reducing reagent (DTT).